SEARCH

SEARCH BY CITATION

References

  • Adams, P.C. (1994) Prevalence of abnormal iron studies in heterozygotes for hereditary hemochromatosis: an analysis of 255 heterozygotes. American Journal of Hematology, 45, 146149.
  • Adams, P.C., Kertesz, A.E., McLaren, C.E., Bamford, A., Chakrabarti, S. (2000) Population screening for haemochromatosis. a comparison of unbound iron binding capacity, transferrin saturation and C282Y genotyping in 5211 voluntary blood donors. Hepatology, 31, 11601164.
  • Allen, K. & Williamson, R. (2000) Screening for hereditary haemochromatosis should be implemented now. British Medical Journal, 320, 183184.
  • Barton, J.C., Preston, B.L., McDonnell, S.M., Rothenberg, B.E. (2001) Severity of iron overload in hemochromatosis: effect of volunteer blood donation before diagnosis. Transfusion, 41, 123129.
  • Bassett, M.L., Halliday, J.W., Ferris, R.A., Powell, L.W. (1984) Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests. Gastroenterology, 87, 628633.
  • Beutler, E., Felitti, V., Gelbart, T., Ho, N. (2000) The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic. Annals of Internal Medicine, 133, 329337.
  • Bhavnani, M., Lloyd, D., Bhattacharyya, A., Marples, J., Elton, P., Worwood, M. (2000) Screening for genetic haemochromatosis in blood samples with raised alanine aminotransferase. Gut, 46, 707710.DOI: 10.1136/gut.46.5.707
  • Bothwell, T.H. & MacPhail, A.P. (1998) Hereditary hemochromatosis: etiologic, pathologic, and clinical aspects. Seminars in Hematology, 35, 5571.
  • Bradley, L.A., Haddow, J.E., Palomaki, G.E. (1996) Population screening for hemochromatosis: expectations based on a study of relatives of symptomatic patients. Journal of Medical Screening, 3, 171177.
  • Braun, J., Donner, H., Plock, K., Rau, H., Usadel, K.H., Badenhoop, K. (1998) Hereditary haemochromatosis mutations (HFE) in patients with Type II diabetes mellitus. Diabetologia, 41, 983984.DOI: 10.1007/s001250051019
  • Bulaj, Z.J., Griffen, L.M., Jorde, L.B., Edwards, C.Q., Kushner, J.P. (1996) Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. New England Journal of Medicine, 335, 17991805.
  • Burt, M.J., George, P.M., Upton, J.D., Collett, J.A., Frampton, C.M.A., Chapman, T.M., Walmsley, T.A., Chapman, B.A. (1998) The significance of haemochromatosis gene mutations in the general population. implications for screening. Gut, 43, 830836.
  • Datz, C., Haas, T., Rinner, H., Sandhofer, F., Patsch, W., Paulweber, B. (1998) Heterozygosity for the C282Y mutation in the hemochromatosis gene is associated with increased serum iron, transferrin saturation, and hemoglobin in young women: a protective role against iron deficiency? Clinical Chemistry, 44, 24292432.
  • De Valk, B., Addicks, M.A., Gosriwatana, I., Lu, S., Hider, R.C., Marx, J.J.M. (2000) Non-transferrin-bound iron is present in serum of hereditary haemochromatosis heterozygotes. European Journal of Clinical Investigation, 30, 248251.DOI: 10.1046/j.1365-2362.2000.00628.x
  • Dorak, M.T., Burnett, A.K., Worwood, M., Sproul, A.M., Gibson, B.E.S. (1999) The C282Y mutation of HFE is another male specific risk factor childhood acute lymphoblastic leukemia. Blood, 94, 39573958.
  • Edwards, C.Q., Griffen, L.M., Goldgar, D., Drummond, C., Skolnick, M.H., J.P. (1988) Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. New England Journal of Medicine, 318, 13551362.
  • Edwards, C.Q., Griffen, L.M., Bulaj, Z.J., Ajioka, R.S., Kushner, J.P. (2000) The iron phenotype of hemochromatosis heterozygotes. In: Hemochromatosis: Genetics, Pathophysiology, Diagnosis and Treatment (ed. by J.C.Barton & C.Q.Edwards), pp. 411418. Cambridge University Press, Cambridge.
  • Feder, J.N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D.A., Basava, A., Dormishian, F., Domingo, R., Ellis, M.C., Fullan, A., Hinton, L.M., Jones, N.L., Kimmel, B.E., Kronmal, G.S., Lauer, P., Lee, V.K., Loeb, D.B., Mapa, F.A., Mcclelland, E., Meyer, N.C., Mintier, G.A., Moeller, N., Moore, T., Morikang, E., Prass, C.E., Quintana, L., Starnes, S.M., Schatzman, R.C., Brunke, K.J., Drayna, D.T., Risch, N.J., Bacon, B.R., Wolff, R.K. (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genetics, 13, 399408.
  • Feder, J.N., Tsuchihashi, Z., Irrinki, A., Lee, V.K., Mapa, F.A., Morikang, E., Prass, C.E., Starnes, S.M., Wolff, R.K., Parkkila, S., Sly, W.S., Schatzman, R.C. (1997) The hemochromatosis founder mutation in HLA-H disrupts beta (2)-microglobulin interaction and cell surface expression. Journal of Biological Chemistry, 272, 1402514028.DOI: 10.1074/jbc.272.22.14025
  • Feder, J.N., Penny, D.M., Irrinki, A., Lee, V.K., Lebron, J.A., Watson, N., Tsuchihashi, Z., Sigal, E., Bjorkman, P.J., Schatzman, R.C. (1998) The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proceedings of the National Academy of Sciences of the United States of America, 95, 14721477.
  • Finch, S.C. & Finch, C.A. (1955) Idiopathic hemochromatosis, an iron storage disease. Medicine, 34, 381430.
  • Florkowski, C.M., George, P.M., Willis, J.A., Stott, M.K., Burt, M.J., Upton, J.D., Nesbit, J., Walmsley, T.A., Scott, R.S. (1999) Haemochromatosis gene mutations C282Y and H63D are not increased in type 2 diabetic patients compared with the Canterbury (New Zealand) general population. Diabetes Research and Clinical Practise, 43, 199203.
  • Frayling, T., Ellard, S., Grove, J., Walker, M., Hattersley, A.T. (1998) C282Y mutation in HFE (haemochromatosis) gene and type 2 diabetes. Lancet, 351, 19331934.
  • Garry, P.J., Koehler, K.M., Simon, T.L. (1995) Iron stores and iron absorption: effects of repeated blood donations. American Journal of Clinical Nutrition, 62, 611620.
  • Guttridge, M.G., Thompson, J., Worwood, M., Darke, C. (1998) Rapid detection of genetic mutations associated with haemochromatosis. Vox Sanguinis, 75, 253256.
  • Haddow, J.E. & Bradley, L.A. (1999) Hereditary haemochromatosis: to screen or not – conditions for screening are not yet fulfilled. British Medical Journal, 319, 531532.
  • Hogg, C. & Modell, B. (1998) Sickle cell and thalassaemia: achieving health gain. Health Education Authority, London.
  • Jeffrey, G., Chakrabarti, S., Hegele, R., Adams, P. (1999) Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in haemochromatosis. Nature Genetics, 22, 325326.DOI: 10.1038/11892
  • Lebron, J.A., Bennett, M.J., Vaughn, D.E., Chirino, A.J., Snow, P.M., Mintier, G.A., Feder, J.N., Bjorkman, P.J. (1998) Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell, 93, 111123.
  • Lynch, S.R., Skikne, B.S., Cook, J.D. (1989) Food iron absorption in idiopathic hemochromatosis. Blood, 74, 21872193.
  • MacLean, R.M., Feeney, G.P., Bowley, S.J., Bowen, D.J., Worwood, M., Collins, P.W. (1999) Factor V Leiden and the common haemochromatosis mutation HFE C282Y: is there an association in familial venous thromboembolic disease? British Journal of Haematology, 107, 210212.
  • McDonnell, S.M., Preston, B.L., Jewell, S.A., Barton, J.C., Edwards, C.Q., Adams, P.C., Yip, R. (1999) A survey of 2,851 patients with hemochromatosis: symptoms and response to treatment. American Journal of Medicine, 106, 619624.
  • Merryweather-Clarke, A.T., Pointon, J.J., Jouanolle, A.M., Rochette, J., Robson, K.J.H. (2000) Geography of HFE C282Y and H63D mutations. Genetic Testing, 4, 183198.DOI: 10.1089/10906570050114902
  • Merryweather-Clarke, A.T., Worwood, M., Parkinson, L., Mattock, C., Pointon, J.J., Shearman, J.D., Robson, K.J.H. (1998) The effect of HFE mutations on serum ferritin and transferrin saturation in the Jersey population. British Journal of Haematology, 101, 369373.DOI: 10.1046/j.1365-2141.1998.00736.x
  • Merryweather-Clarke, A.T., Pointon, J.J., Shearman, J.D., Robson, K.J.H., Jouanolle, A.M., Mosser, A., David, V., Le Gall, J.Y., Halsall, D.J., Elsey, T.S., Kelly, A., Cox, T.M., Clare, M., Bomford, A., Vandwalle, J.L., Rochette, J., Borot, N., Coppin, H., Roth, M.P., Ryan, E., Crowe, J., Totaro, A., Gasparini, P., Roetto, A., Gamaschella, C., Darke, C., Wallace, D.F., Saeb-Parsy, K., Dooley, J.S., Worwood, M., Walker, A.P. (1999) Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results. Nature Genetics, 23, 271.
  • Milman, N. & Søndergaard, M. (1984) Iron stores in male blood donors evaluated by serum ferritin. Transfusion, 24, 464468.
  • Motulsky, A.G. (1979) Genetics of hemochromatosis. New England Journal of Medicine, 301, 1291.
  • Niederau, C., Fischer, R., Purschel, A., Stremmel, W., Haussinger, D., Strohmeyer, G. (1996) Long-term survival in patients with hereditary hemochromatosis. Gastroenterology, 110, 11071119.
  • Olynyk, J.K., Cullen, D.J., Aquilia, S., Rossi, E., Summerville, L., Powell, L.W. (1999) A population-based study of the clinical expression of the hemochromatosis gene. New England Journal of Medicine, 341, 718724.
  • Persijn, J.-P., Van Der Slik, W., Riethorst, A. (1971) Determination of serum iron and latent iron-binding capacity (LIBC). Clinica Chimica Acta, 35, 9198.
  • Pietrangelo, A., Montosi, G., Totaro, A., Garuti, C., Conte, D., Cassanelli, S., Fraquelli, M., Sardini, C., Vasta, F., Gasparini, P. (1999) Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene. New England Journal of Medicine, 341, 725732.
  • Pintar, J., Skikne, B.S., Cook, J.D. (1981) A screening test for assessing iron status. Blood, 59, 110113.
  • Powell, L.W., Summers, K.M., Board, P.G., Axelsen, E., Webb, S., Halliday, J.W. (1990) Expression of hemochromatosis in homozygous subjects. Implications for early diagnosis and prevention. Gastroenterology, 98, 16251632.
  • Roest, M., Van Der Schouw, Y.T., DeValk, B., Marx, J.J.M., Tempelman, M.J., DeGroot, P.G., Sixma, J.J., Banga, J.D. (1999) Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women. Circulation, 100, 12681273.
  • Roetto, A., Totaro, A., Piperno, A., Piga, A., Longo, F., Garozzo, G., Cali, A., De Gobbi, M., Gasparini, P., Camaschella, C. (2001) New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. Blood, 97, 25552560.
  • Rossi, E., Olynyk, J.J., Cullen, D.J., Papadopoulos, G., Bulsara, M., Summerville, L., Powell, L.W. (2000) Compound heterozygous hemochromatosis genotype predicts increased iron and erythrocyte indices in women. Clinical Chemistry, 46, 162166.
  • Sampietro, M., Piperno, A., Lupica, L., Arosio, C., Vergani, A., Corbetta, N., Malosio, I., Mattioli, M., Fracanzani, A.L., Cappellini, M.D., Fiorelli, G., Fargion, S. (1998) High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda. Hepatology, 27, 181184.
  • Sheldon, J.H. (1935) Haemochromatosis. Oxford University Press, London.
  • The UK Haemochromatosis Consortium (1997) A simple genetic test identifies 90% of UK patients with haemochromatosis. Gut, 41, 841844.
  • Tuomainen, T.P., Kontula, K., Nyyssonen, K., Lakka, T.A., Helio, T., Salonen, J.T. (1999) Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation – a prospective cohort study in men in eastern Finland. Circulation, 100, 12741279.
  • Walters, G.O., Miller, F.M., Worwood, M. (1973) Serum ferritin concentration and iron stores in normal subjects. Journal of Clinical Pathology, 26, 770772.
  • Willis, G., Wimperis, J.Z., Lonsdale, R., Fellows, I.W., Watson, M.A., Skipper, L.M., Jennings, B.A. (2000) Incidence of liver disease in people with HFE mutations. Gut, 46, 401404.DOI: 10.1136/gut.46.3.401
  • Worwood, M. (1990) Ferritin. Blood Reviews, 4, 259269.
  • Worwood, M. (1994a) Genetics of haemochromatosis. Bailliere's Clinical Haematology, 7, 903918.
  • Worwood, M. (1994b) Laboratory determination of iron status. In: Iron Metabolism in Health and Disease (ed. by J.H.Brock, J.W.Halliday, M.J.Pippard & L.W.Powell), pp. 449476. W.B.Saunders, London.
  • Worwood, M. (1995) Iron deficiency anaemia. In: Practical Haematology (ed. by Sir J.V.Dacie & S.M. Lewis), 8th edn, pp. 437444. Churchill-Livingstone, Edinburgh.
  • Worwood, M. (1999) Inborn errors of metabolism: iron. British Medical Bulletin, 55, 556567.
  • Worwood, M. (2001) Iron deficiency anaemia and iron overload. In: Practical Haematology (ed. by S.M.Lewis, B.Bain & I.Bates), 9th edn. Harcourt Publishers, London ( in press).
  • Worwood, M., Jackson, H.A., Feeney, G.P., Edwards, C., Bowen, D.J. (1999) A single tube heteroduplex PCR for the common HFE genotypes. Blood, 94, 405a.
  • Yang, Q.H., McDonnell, S.M., Khoury, M.J., Cono, J., Parrish, R.G. (1998) Hemochromatosis-associated mortality in the United States from 1979 to 1992: an analysis of multiple-cause mortality data. Annals of Internal Medicine, 129, 946953.
  • Zhou, X.Y., Tomatsu, S., Fleming, R.E., Parkkila, S., Waheed, A., Jiang, J.X., Fei, Y., Brunt, E.M., Ruddy, D.A., Prass, C.E., Schatzman, R.C., Oneill, R., Britton, R.S., Bacon, B.R., Sly, W.S. (1998) HFE gene knockout produces mouse model of hereditary hemochromatosis. Proceedings of the National Academy of Sciences of the United States of America, 95, 24922497.